UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 42

Sortiert nach

Early and effective treatment of KCNQ2 encephalopathy

Epilepsia (Copenhagen), 2015-05, Vol.56 (5), p.685-691

2015

Volltextzugriff (PDF)

A Quantitative Electrophysiological Biomarker of Duplication 15q11.2-q13.1 Syndrome

PloS one, 2016-12, Vol.11 (12), p.e0167179-e0167179

2016

Volltextzugriff (PDF)

Angelman syndrome in adolescence and adulthood: A retrospective chart review of 53 cases

American journal of medical genetics. Part A, 2018-06, Vol.176 (6), p.1327-1334

2018

Volltextzugriff (PDF)

Neurologic Manifestations of Angelman Syndrome

Pediatric neurology, 2013-04, Vol.48 (4), p.271-279

2013

Volltextzugriff (PDF)

The Interstitial Duplication 15q11.2-q13 Syndrome Includes Autism, Mild Facial Anomalies and a Characteristic EEG Signature

Autism research, 2013-08, Vol.6 (4), p.268-279

2013

Volltextzugriff (PDF)

Angelman syndrome in adulthood

American journal of medical genetics. Part A, 2015-02, Vol.167A (2), p.331-344

2015

Volltextzugriff (PDF)

A survey of seizures and current treatments in 15q duplication syndrome

Epilepsia (Copenhagen), 2014-03, Vol.55 (3), p.396-402

2014

Volltextzugriff (PDF)

Delta rhythmicity is a reliable EEG biomarker in Angelman syndrome: a parallel mouse and human analysis

Journal of neurodevelopmental disorders, 2017-05, Vol.9 (1), p.17-17, Article 17

2017

Volltextzugriff (PDF)

Understanding relationships between autism, intelligence, and epilepsy: a cross‐disorder approach

Developmental medicine and child neurology, 2013-02, Vol.55 (2), p.146-153

2013

Volltextzugriff (PDF)

Epilepsy in Angelman syndrome: A questionnaire‐based assessment of the natural history and current treatment options

Epilepsia (Copenhagen), 2009-11, Vol.50 (11), p.2369-2376

2009

Volltextzugriff (PDF)

Hippocampal Abnormalities in Magnetic Resonance Imaging (MRI) of 15q Duplication Syndromes

Journal of child neurology, 2015-03, Vol.30 (3), p.333-338

2015

Volltextzugriff (PDF)

Angelman syndrome genotypes manifest varying degrees of clinical severity and developmental impairment

Molecular psychiatry, 2021-07, Vol.26 (7), p.3625-3633

2021

Volltextzugriff (PDF)

The Use of Magnetic Resonance Spectroscopy in the Evaluation of Pediatric Patients With Seizures

Pediatric neurology, 2016-05, Vol.58, p.57-66

2016

Volltextzugriff (PDF)

Erratum to: Delta rhythmicity is a reliable EEG biomarker in Angelman syndrome: a parallel mouse and human analysis

Journal of neurodevelopmental disorders, 2017-07, Vol.9 (1), p.30-30, Article 30

2017

Volltextzugriff (PDF)

Seizure treatment in Angelman syndrome: A case series from the Angelman Syndrome Clinic at Massachusetts General Hospital

Epilepsy & behavior, 2016-07, Vol.60, p.138-141

2016

Volltextzugriff (PDF)

If not Angelman, what is it? a review of Angelman-like syndromes

American journal of medical genetics. Part A, 2014-04, Vol.164A (4), p.975-992

2014

Volltextzugriff (PDF)

The STARS Phase 2 Study: A Randomized Controlled Trial of Gaboxadol in Angelman Syndrome

Neurology, 2021-02, Vol.96 (7), p.e1024

2021

Volltextzugriff (PDF)

Parent Description of Anxiety in Angelman Syndrome

Journal of autism and developmental disorders, 2022-08, Vol.52 (8), p.3612-3625

2022

Volltextzugriff (PDF)

Behavioral characterization of dup15q syndrome: Toward meaningful endpoints for clinical trials

American journal of medical genetics. Part A, 2020-01, Vol.182 (1), p.71-84

2020

Volltextzugriff (PDF)

Impact of pediatric epilepsy on sleep patterns and behaviors in children and parents

Epilepsia (Copenhagen), 2012-07, Vol.53 (7), p.1162-1169

2012

Volltextzugriff (PDF)

Low glycemic index treatment for seizure control in Angelman syndrome: A case series from the Center for Dietary Therapy of Epilepsy at the Massachusetts General Hospital

Epilepsy & behavior, 2017-03, Vol.68, p.45-50

2017

Volltextzugriff (PDF)

3.1 Topline Results From a Phase 2 Adult and Adolescent Angelman Syndrome Clinical Trial: A Randomized, Double-Blind, Safety and Efficacy Study of Gaboxadol (Ov101)

Journal of the American Academy of Child and Adolescent Psychiatry, 2018-10, Vol.57 (10), p.S182-S182

2018

Volltextzugriff (PDF)

Tolerability and dosing experience of intravenous levetiracetam in children and infants

Epilepsy research, 2008-10, Vol.81 (2), p.143-147

2008

Volltextzugriff (PDF)

Myoclonus in Angelman syndrome

Epilepsy & behavior, 2018-05, Vol.82, p.170-174

2018

Volltextzugriff (PDF)

Epilepsy and the sleep–wake patterns found in Angelman syndrome

Epilepsia (Copenhagen), 2009-11, Vol.50 (11), p.2497-2500

2009

Volltextzugriff (PDF)

1 – 25 von 42

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(41)

Publikationsform

Sprache

Englisch
(42)
Japanisch
(11)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Early and effective treatment of KCNQ2 encephalopathy

A Quantitative Electrophysiological Biomarker of Duplication 15q11.2-q13.1 Syndrome

Angelman syndrome in adolescence and adulthood: A retrospective chart review of 53 cases

Neurologic Manifestations of Angelman Syndrome

The Interstitial Duplication 15q11.2-q13 Syndrome Includes Autism, Mild Facial Anomalies and a Characteristic EEG Signature

Angelman syndrome in adulthood

A survey of seizures and current treatments in 15q duplication syndrome

Delta rhythmicity is a reliable EEG biomarker in Angelman syndrome: a parallel mouse and human analysis

Understanding relationships between autism, intelligence, and epilepsy: a cross‐disorder approach

Epilepsy in Angelman syndrome: A questionnaire‐based assessment of the natural history and current treatment options

Hippocampal Abnormalities in Magnetic Resonance Imaging (MRI) of 15q Duplication Syndromes

Angelman syndrome genotypes manifest varying degrees of clinical severity and developmental impairment

The Use of Magnetic Resonance Spectroscopy in the Evaluation of Pediatric Patients With Seizures

Erratum to: Delta rhythmicity is a reliable EEG biomarker in Angelman syndrome: a parallel mouse and human analysis

Seizure treatment in Angelman syndrome: A case series from the Angelman Syndrome Clinic at Massachusetts General Hospital

If not Angelman, what is it? a review of Angelman-like syndromes

The STARS Phase 2 Study: A Randomized Controlled Trial of Gaboxadol in Angelman Syndrome

Parent Description of Anxiety in Angelman Syndrome

Behavioral characterization of dup15q syndrome: Toward meaningful endpoints for clinical trials

Impact of pediatric epilepsy on sleep patterns and behaviors in children and parents

Low glycemic index treatment for seizure control in Angelman syndrome: A case series from the Center for Dietary Therapy of Epilepsy at the Massachusetts General Hospital

3.1 Topline Results From a Phase 2 Adult and Adolescent Angelman Syndrome Clinical Trial: A Randomized, Double-Blind, Safety and Efficacy Study of Gaboxadol (Ov101)

Tolerability and dosing experience of intravenous levetiracetam in children and infants

Myoclonus in Angelman syndrome

Epilepsy and the sleep–wake patterns found in Angelman syndrome

Suchergebnisse filtern